Need to test the arterial inflammation hypothesis

[1] Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia [J]. CIRCULATION, 2001, 104 (04) : 455 - 460

[2] Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice [J]. JOURNAL OF HYPERTENSION, 2001, 19 (06) : 1083 - 1088

[3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70

[4] Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08) : 884 - +

[5] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[6] C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (11) : 1235 - 1239

[7] Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability [J]. CIRCULATION, 1999, 99 (07) : 855 - 860

[8] Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) : 1512 - 1521

[9] Blood pressure and inflammation in apparently healthy men [J]. HYPERTENSION, 2001, 38 (03) : 399 - 403

[10] Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention [J]. CIRCULATION, 2002, 105 (06) : 691 - 696

[1] Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia [J]. CIRCULATION, 2001, 104 (04) : 455 - 460

[2] Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice [J]. JOURNAL OF HYPERTENSION, 2001, 19 (06) : 1083 - 1088

[3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70

[4] Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08) : 884 - +

[5] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[6] C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (11) : 1235 - 1239

[7] Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability [J]. CIRCULATION, 1999, 99 (07) : 855 - 860

[8] Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) : 1512 - 1521

[9] Blood pressure and inflammation in apparently healthy men [J]. HYPERTENSION, 2001, 38 (03) : 399 - 403

[10] Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention [J]. CIRCULATION, 2002, 105 (06) : 691 - 696